Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictive value of a low serum trypsinogen.

W M Steinberg, S S Goldstein, N D Davis

    Digestive Diseases and Sciences
    |June 1, 1985
    PubMed
    Summary

    This study examined the usefulness of low serum trypsinogen levels in diagnosing chronic exocrine pancreatic disorders and diabetes. Researchers tested 418 emergency room patients and found that 2.4% had low trypsinogen. Of these, four had clear signs of pancreatic disease, and three without initial symptoms were later diagnosed with chronic pancreatic issues. Three diabetic patients also had low trypsinogen and coexisting pancreatic disease. The findings suggest that low trypsinogen may be a reliable marker for these conditions, even when symptoms are absent. The authors propose that this test could help detect chronic pancreatic disorders earlier in clinical practice.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Childhood food insecurity and incident diabetes: A longitudinal cohort study of 34 042 children in Ontario, Canada.

    Diabetic medicine : a journal of the British Diabetic Association·2020
    Same author

    Age at migration and the risk of psychotic disorders: a systematic review and meta-analysis.

    Acta psychiatrica Scandinavica·2020
    Same author

    Concordance between health administrative data and survey-derived diagnoses for mood and anxiety disorders.

    Acta psychiatrica Scandinavica·2019
    Same author

    First Report of Calosphaeria pulchella Associated with Branch Dieback of Sweet Cherry Trees in California.

    Plant disease·2019
    Same author

    Calosphaeria Canker of Sweet Cherry Caused by Calosphaeria pulchella in California and South Australia.

    Plant disease·2019
    Same author

    Improvements in the method of radiation anomaly detection by spectral comparison ratios.

    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2016

    Area of Science:

    • Gastroenterology and Hepatology
    • Endocrinology and Metabolic Disorders
    • Clinical Diagnostic Testing

    Background:

    Prior research has shown that low serum trypsinogen levels may appear in individuals with chronic exocrine pancreatic disorders and diabetes mellitus. However, the diagnostic accuracy of this marker has not been widely tested in general populations. Established knowledge includes the role of trypsinogen in pancreatic function, but uncertainty remains about its predictive value in broader clinical settings. This gap motivated the need for a study using a non-selected patient group. No prior work had resolved how often low trypsinogen occurs in emergency room patients. The relationship between trypsinogen levels and diabetes remains unclear in many cases. This study aimed to clarify whether low trypsinogen could serve as a diagnostic tool. The findings may help improve early detection of chronic pancreatic conditions.

    Purpose Of The Study:

    The aim of this study was to evaluate the diagnostic usefulness of low serum trypsinogen in a general emergency room population. Researchers focused on whether this marker could predict chronic exocrine pancreatic disorders. They also examined if low trypsinogen levels were associated with diabetes mellitus. The study sought to determine the frequency of low trypsinogen in a non-selected group of patients. The motivation came from prior observations in smaller, specific populations. This work aimed to validate those findings in a broader setting. The researchers wanted to assess the marker’s sensitivity and specificity. Their goal was to provide evidence for its potential clinical application.

    Keywords:
    serum trypsinogen levelspancreatic disorder diagnosisdiabetes and pancreatic healthclinical diagnostic markers

    Frequently Asked Questions

    The study suggests that low trypsinogen levels may predict chronic exocrine pancreatic disorders, even in asymptomatic patients.

    Researchers used immunoassay techniques to measure trypsinogen levels in 418 emergency room patient samples.

    Follow-up confirmed chronic pancreatic disease in three asymptomatic patients, highlighting the marker’s predictive value.

    Three of 37 diabetic patients had low trypsinogen and coexisting chronic pancreatic disease, suggesting a possible link.

    Related Experiment Videos

    Main Methods:

    The study involved 488 consecutive emergency room patients who had serum amylase tests performed. Of these, 418 samples were preserved for trypsinogen analysis using immunoassay techniques. Researchers measured trypsinogen levels and categorized results as low (below 10 ng/ml). They reviewed medical records for evidence of chronic pancreatic disease and diabetes. Follow-up assessments were conducted for patients without initial diagnostic signs. Clinical data included patient history, physical findings, and laboratory results. The analysis focused on the association between low trypsinogen and known conditions. Researchers compared outcomes between patients with and without low trypsinogen.

    Main Results:

    Of the 418 patients tested, 10 (2.4%) had low serum trypsinogen levels. Four of these had clear evidence of chronic exocrine pancreatic disorders. Six patients lacked initial clinical signs of pancreatic disease. Follow-up confirmed chronic pancreatic disease in three of these six cases. Three of 37 patients with diabetes had low trypsinogen and coexisting pancreatic disease. No other conditions were consistently linked to low trypsinogen levels. The marker showed no significant association with non-pancreatic conditions. These findings suggest a strong correlation between low trypsinogen and chronic pancreatic disorders.

    Conclusions:

    The authors propose that low serum trypsinogen is a strong predictor of chronic exocrine pancreatic disorders. Their findings suggest this marker may be useful in diagnostic settings. The study supports the use of trypsinogen testing in patients with suspected pancreatic disease. The association with diabetes and pancreatic disease was also noted. No other conditions were reliably linked to low trypsinogen levels. The researchers emphasize the need for further validation in larger populations. The marker’s specificity and sensitivity were highlighted in this analysis. These results may guide future diagnostic protocols in emergency medicine.

    2.4% of the 418 tested patients had low trypsinogen levels, defined as less than 10 ng/ml.

    The authors suggest that low trypsinogen may serve as a diagnostic tool for chronic exocrine pancreatic disorders.